bexarotene targets PPARγ
Evidence from:
primary |
all sources
Evidence (1 sources)
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.
(2014)
PMID:25368578
cited
bexarotene ... through the actions of peroxisome proliferator-activated nuclear receptor gamma
confidence: 0.93